Biggest News Aggregation in the World
📰 Case Series News

Page 2 - Case Series News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Case Series. Real-time updates on events, politics, business and more.

Numinus Wellness Inc chief clinical officer's Reid Robison's contributions to mental health disorder studies featured in four peer-reviewed papers

Numinus Wellness Inc announced that its chief clinical officer Reid Robison has contributed to studies published in four peer-reviewed papers thus far in...
Payton Nyquvest Reid Robison Brain Sciences Numinus Wellness Inc Group Psychotherapy For Frontline Healthcare Workers Post Traumatic Stress Disorder

F. Hoffmann-La Roche Ltd: Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed control in infants from birth

The HAVEN 7 study was designed to further confirm the benefit of preventative treatment (prophylaxis) with Hemlibra from birth in previously untreated or minimally treated infants with severe haemophilia
United States United Kingdom Levi Garraway Mabthera Rituxan Gazyva Gazyvaro Sabine Borngr

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed control in infants from birth

The HAVEN 7 study was designed to further confirm the benefit of preventative treatment with Hemlibra from birth in previously untreated or minimally treated infants with severe haemophilia A without... | December 11, 2022
United States United Kingdom Levi Garraway Loren Kalm Sabine Borngr Nathalie Altermatt

Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed control in infants from birth

Investegate announcements from F. Hoffmann-La Roche Ltd, Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed control in infants from birth
United States United Kingdom Levi Garraway Loren Kalm Nathalie Altermatt Chugai Pharmaceutical Co Ltd

F. Hoffmann-La Roche Ltd: Roche to present data at ASH 2022 showcasing strength of haematology portfolio and expanding into new areas to address more patient needs

Interim data from phase III HAVEN 7 study reinforce Hemlibra's efficacy and safety in infants with severe haemophilia A without factor VIII inhibitors1New and updated data support use of Polivy in diffuse
United States Polatuzumab Vedotin Levi Garraway Mabthera Rituxan Gazyva Gazyvaro Sabine Borngr

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science